ABBOTINDIA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 4.0
| Stock Code | ABBOTINDIA | Market Cap | 59,071 Cr. | Current Price | 27,790 ₹ | High / Low | 37,000 ₹ |
| Stock P/E | 38.1 | Book Value | 2,247 ₹ | Dividend Yield | 1.71 % | ROCE | 44.9 % |
| ROE | 34.5 % | Face Value | 10.0 ₹ | DMA 50 | 26,799 ₹ | DMA 200 | 28,012 ₹ |
| Chg in FII Hold | 0.08 % | Chg in DII Hold | -0.07 % | PAT Qtr | 395 Cr. | PAT Prev Qtr | 376 Cr. |
| RSI | 61.2 | MACD | 462 | Volume | 16,139 | Avg Vol 1Wk | 13,529 |
| Low price | 25,150 ₹ | High price | 37,000 ₹ | PEG Ratio | 2.14 | Debt to equity | 0.04 |
| 52w Index | 22.3 % | Qtr Profit Var | 7.60 % | EPS | 730 ₹ | Industry PE | 31.6 |
📈 Chart Patterns: ABBOTINDIA is trending upward, trading above its 50 DMA (26,799 ₹) but slightly below 200 DMA (28,012 ₹), showing short-term strength with medium-term resistance.
📊 Moving Averages: Current price (27,790 ₹) is above 50 DMA, reflecting bullish bias, but needs to cross 200 DMA for stronger confirmation.
📉 RSI: At 61.2, RSI indicates healthy momentum, approaching overbought territory.
📈 MACD: Strongly positive at 462, confirming bullish crossover and momentum continuation.
📊 Bollinger Bands: Price is near the upper band, suggesting strong momentum but risk of short-term pullback.
📉 Volume Trends: Current volume (16,139) is slightly above average weekly volume (13,529), showing steady participation in the rally.
🎯 Entry Zone: 27,200 ₹ – 27,500 ₹ (near 50 DMA support)
🚪 Exit Zone: 28,500 ₹ – 29,000 ₹ (resistance near 200 DMA)
📌 Trend Status: Trending upward with bullish bias
Positive
- Strong ROCE (44.9%) and ROE (34.5%) highlight efficiency
- EPS at 730 ₹ reflects robust profitability
- Dividend yield at 1.71% provides income support
- MACD strongly positive, confirming bullish momentum
- FII holdings increased (+0.08%)
Limitation
- Price still below 200 DMA, medium-term resistance intact
- High P/E (38.1) vs industry PE (31.6)
- 52-week index at 22.3% shows limited recovery from highs
- Volume participation moderate, not aggressive
Company Negative News
- DII holdings decreased (-0.07%)
- Valuation concerns due to premium multiples
Company Positive News
- Quarterly PAT improved to 395 Cr from 376 Cr (+7.6%)
- Strong efficiency metrics (ROE/ROCE)
- Dividend yield supports investor sentiment
Industry
- Industry PE at 31.6 highlights sector stability
- Pharma sector showing steady demand and resilience
Conclusion
⚖️ ABBOTINDIA is trending upward with bullish signals supported by MACD, RSI, and price above 50 DMA. Entry near 27,200–27,500 ₹ offers favorable risk-reward, while resistance at 28,500–29,000 ₹ may cap short-term upside. Long-term investors should be cautious of premium valuations, but strong fundamentals and profit growth provide resilience for momentum trades.
I can extend this into a swing trade strategy with holding period guidance, or prepare a peer benchmarking overlay comparing ABBOTINDIA’s valuation and momentum against pharma sector peers.